-
-
-
-
-
-
-
Atossa Therapeutics (ATOS) Announces $10M Stock Repurchase Program
-
-
-
-
-
-
-
Atossa Therapeutics (ATOS) Acquires Stake in Dynamic Cell Therapies
-
-
-
-
-
-
-
Exclusive: Worldline $9.2 billion Ingenico deal may need EU concessions - sources
-
-
-
-
-
-
-
Atossa Genetics (ATOS) to Host Conference Call to Present Additional Findings from Phase 1 Study of Oral Endoxifen
-
-
-
-
-
-
-
Atossa Genetics Announces Second Quarter 2015 Financial Results and Provides Company Update; Achieves Total Revenue for Q2 2015 of $2.7 Million
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 2/26: (CYTX) (ATOS) (ELX) Higher; (CLRX) (ESSX) (BIOC) Lower
-
-
-
-
-
-
-
Pre-Open Stock Movers 1/24: (BDSI) (OTEX) (JNPR) Higher; (ATOS) (PTCT) (ISRG) Lower (more...)
-
1,157,741 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

